《盈警響號》金蝶國際(00268.HK)料去年淨虧損擴大至介乎3.6億至4.2億人幣
金蝶國際(00268.HK)發盈警,預計截至2022年12月31日止十二個月,錄得總收入將介乎於約48億至約50億元人民幣(下同)之間,較2021年同期增長約15%至20%;歸屬於公司權益持有人應佔虧損則將錄得介乎於約3.62億元至約4.23億元之間,2021年同期淨虧損約為3.02億元。
集團表示,歸屬於公司權益持有人應佔虧損主要是本年度集團持續加大其對雲產品尤其是金蝶雲‧星瀚及HR SaaS的研發投入;及去年新冠疫情持續,使得集團部分營銷和交付活動展開受阻。(ca/k)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.